ADC Therapeutics (ADCT) Prepaid Assets (2019 - 2026)
ADC Therapeutics (ADCT) posted quarterly Prepaid Assets of $5.7 million for Q1 2026, down 20.97% year-on-year from $7.2 million in Q1 2025, and down 6.74% on a QoQ basis from $6.1 million in Q4 2025.
ADC Therapeutics (ADCT) Prepaid Assets (2019 - 2026) Analysis & Trends
ADC Therapeutics (ADCT) has reported Prepaid Assets for 8 consecutive years, with $5.7 million the latest figure, recorded in Q1 2026.
- Quarterly Prepaid Assets fell 20.97% year-over-year to $5.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.7 million (down 20.97% YoY) and the FY2025 annual result came in at $6.1 million, down 35.62% from the prior year.
- Prepaid Assets slipped to $5.7 million in Q1 2026 per ADCT's latest filing, from $6.1 million in the prior quarter.
- Over the last five years, Prepaid Assets for ADCT reached as high as $27.2 million in Q1 2023 and fell as low as $5.7 million in Q2 2025.
- A 5-year average of $14.4 million and a median of $16.7 million in 2024 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2023 — Prepaid Assets soared 81.09% — and 2025, when it plunged 68.18%.
- Year by year, Prepaid Assets stood at $23.5 million in 2022, then tumbled by 55.97% to $10.3 million in 2023, then decreased by 8.64% to $9.4 million in 2024, then tumbled by 35.62% to $6.1 million in 2025, then decreased by 6.74% to $5.7 million in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $5.7 million, $6.1 million, and $5.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ADC Therapeutics | 189.60 Mn | -41.41 Mn | 17.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.67 Mn |
| Dec 31, 2025 | 6.08 Mn |
| Sep 30, 2025 | 5.93 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Mar 31, 2025 | 7.18 Mn |
| Dec 31, 2024 | 9.45 Mn |
| Sep 30, 2024 | 18.63 Mn |
| Jun 30, 2024 | 17.18 Mn |
| Mar 31, 2024 | 16.74 Mn |
| Dec 31, 2023 | 10.34 Mn |
| Sep 30, 2023 | 21.28 Mn |
| Jun 30, 2023 | 22.00 Mn |
| Mar 31, 2023 | 27.17 Mn |
| Dec 31, 2022 | 23.50 Mn |
| Sep 30, 2022 | 18.24 Mn |
| Jun 30, 2022 | 12.15 Mn |
| Mar 31, 2022 | 18.25 Mn |
| Dec 31, 2021 | 17.30 Mn |
| Sep 30, 2021 | 14.31 Mn |
| Jun 30, 2021 | 12.75 Mn |